Showing 51 - 60 of 77
Prompt and affordable access to essential medicines is a component of almost all domestic and global public health models. As is now well known, the availability and costs of both brand and generic drugs is a function of traditional patent law incentives. Less known, however, is that generic...
Persistent link: https://www.econbiz.de/10014189151
This article analyzes the benefits and costs of replacing Canada's ten different provincial formularies with one single national formulary. The 2002 Romanow Commission on the Future of Health Care in Canada recommended that Canada should have a National Drug Agency which would maintain a...
Persistent link: https://www.econbiz.de/10005198317
Parallel imports are genuine products imported without the authorization of the trademark or copyright owner in a country. Authorized dealers have employed trademark and copyright law to exclude parallel imports using claims of infringement. Our assertion is that trademark and copyright laws are...
Persistent link: https://www.econbiz.de/10005704771
Persistent link: https://www.econbiz.de/10005763998
Persistent link: https://www.econbiz.de/10005763999
This paper offers an economic rationale for compulsory licensing of needed medicines in developing countries. The patent system is based on a trade-off between the “deadweight losses†caused by market power and the incentive to innovate created by increased profits from monopoly...
Persistent link: https://www.econbiz.de/10005764001
This work examines the effects of large-scale integration of wind powered electricity generation in a deregulated energy-only market on loads (in terms of electricity prices and supply reliability) and dispatchable conventional power suppliers. Hourly models of wind generation time series, load...
Persistent link: https://www.econbiz.de/10008494624
Persistent link: https://www.econbiz.de/10005131221
Persistent link: https://www.econbiz.de/10005136144
Persistent link: https://www.econbiz.de/10005183779